Median Technologies: H1 2026 Financial Communication Calendar

The Company will participate in upcoming investor events:

Allinvest Securities Biomed Forum
January 29, 2026 – Paris, France

Investor Access Conference
April 8-9, 2026– Paris, France

TP ICAP Midcap Annual Conference
May 6-7, 2026 - Paris, France

Portzamparc Mid & Small Caps Conference
June 24-25, 2026 - Paris, France

Please get in touch through the respective event booking systems, if you would like to request a meeting with Median management at these events. Events are for institutional investors only.

About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis®, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com. 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260114920598/en/